Navigation Links
NeoStem's Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
Date:3/5/2008

NEW YORK, March 5 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, today announced that Denis Rodgerson, Ph.D., NeoStem's Director of Stem Cell Science will lecture at The University of Nevada Las Vegas campus this evening. In October 2007, NeoStem announced the expansion of its network of adult stem cell collection centers into Las Vegas, the first in the region.

Dr. Rodgerson's lecture, entitled, "Stem Cells & Regenerative Medicine: Past, Present & Future," will address the evolving nature of stem cell research and applications as well as NeoStem's proprietary Very Small Embryonic Like Stem Cells (VSELs) technology and its potential role in the market.

Dr. Rodgerson has published more than 150 articles in medical and scientific literature and is the holder of several patents. He is an inventor of the proprietary process that serves as the basis for NeoStem's platform stem cell collection business and was the founder of NeoStem's predecessor company. He has been a consultant to many institutions and corporations, including NASA, National Bureau of Standards, Hewlett Packard, and Beckman Instruments. Prior to founding NeoStem, Dr. Rodgerson founded StemCyte, Inc., an umbilical cord blood banking company, where he served as Chief Operating Officer and Senior Vice President until 2002. He is also Professor Emeritus of Pathology and Laboratory Medicine at the UCLA School of Medicine.

About NeoStem, Inc.

NeoStem is managing a growing nationwide network of adult stem cell collection centers, enabling people to donate and store their own (autologous) stem cells when they are young and healt
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors
2. BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
3. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
4. Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
5. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
6. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors
7. Cylene Pharmaceuticals Appoints Kenna Anderes, Ph.D. as Vice President of Cancer Biology
8. Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
9. Neurobiological Technologies, Inc. Reports Retirement of Ronald E. Cape, Ph.D., from Board
10. WellGen, Inc. Names Nancy E. Rawson, Ph.D., Chief Scientific Officer
11. Sunesis Pharmaceuticals Appoints Lesley A. Stolz, Ph.D., Vice President, Corporate and Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... King of Prussia, PA (PRWEB) May 21, 2015 ... that Julia O’Neill has joined the firm as senior ... more than 30 years of experience in the management ... the vaccines, biologics, pharmaceutical and chemical industries. , “We’re ... enhance our longstanding capabilities in data analytics,” said Dr. ...
(Date:5/20/2015)...  Select Medical Corporation ("Select") (NYSE: SEM ... early termination of the waiting period under the ... amended, applicable to the acquisition of Concentra Inc. ... that Select has created with Welsh, Carson, Anderson & ... MJ Acquisition Corporation has signed a definitive purchase ...
(Date:5/20/2015)... May 20, 2015  Haemonetics Corporation (NYSE: HAE ... & CEO, will present at The Jefferies 2015 Global ... on June 1 st , 2015 at 8:30am Eastern ... Concannon,s presentation live via webcast at: http://wsw.com/webcast/jeff88/hae ... HAE ) is a global healthcare company dedicated ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... Good Start Genetics ,™ Inc., an innovative molecular diagnostics company ... today announced it completed the initial closing of a $14 ... existing investors OrbiMed Advisors , Safeguard Scientifics, Inc. ... Sciences . Proceeds from this financing will be used to ...
... Corporation (NASDAQ: LIFE ) will exhibit ... cancer research during the American Association of Cancer Research ... April 4, in Chicago, Illinois. In addition, several of ... "From basic discovery of biomarkers to validation of ...
... of physicists at UC Santa Barbara has seen the light, ... and low-frequency laser beams at a semiconductor, the researchers caused ... smashed back into the cores they left behind. This recollision ... the current issue of the science journal Nature . ...
Cached Biology Technology:Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 2Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 3Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 4Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team 5Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 2Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 3Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 4Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012 5UCSB Physicists mix 2 lasers to create light at many frequencies 2UCSB Physicists mix 2 lasers to create light at many frequencies 3
(Date:5/14/2015)... , May 14, 2015  Verificient ... identity verification and online remote proctoring, announced ... software-as-a-service (SaaS) company and creator of the ... of the two companies will benefit from ... Canvas. As a fully integrated ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/7/2015)... Fingerprint Cards (FPC) introduces ... FPC,s smallest touch fingerprint sensors to date.  ... integration on the backside of the phone, and ... to integrate touch fingerprint sensors in the OEMs, ... for module manufacturers to customize the look and ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... the aid of a straightforward experiment, researchers have provided ... how ancient organic molecules came together to form the ... online this week in JBC , demonstrated how ... length. RNA, the single-stranded precursor to DNA, normally ...
... ON A new technology that could help physicians ... and potentially fatal complication called preeclampsia has been developed ... Health Research Institute of Lawson Health Research Institute. ... have changed levels in the placenta of women who ...
... Institute of Ultrasound in Medicine (AIUM) 2009 Annual Convention ... Marquis Hotel in New York City, New York, Thursday ... numbers indicate that 2009 will prove to be better ... regarded as the AIUM,s most successful convention in history. ...
Cached Biology News:New technology aims to reduce maternal and neonatal deaths 2AIUM to Host 2009 Annual Convention in New York 2
... Cell Cultures (ECACC) in conjunction with the ... of England, Bristol, UK, have produced standardised ... HER2, oestrogen and progresterone receptor assays. The ... formalin fixed, breast cancer cell lines; MDA-MD-361, ...
... When Ambion introduced the highly potent TURBO ... a new standard was set in DNA removal ... of DNase I that is much more efficient ... trace amounts of unwanted DNA. TURBO DNase binds ...
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
PP2B-Abeta (C-20)...
Biology Products: